Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Direct-to-Consumer Laboratory Testing Market 

5.1. COVID-19 Landscape: Direct-to-Consumer Laboratory Testing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Direct-to-Consumer Laboratory Testing Market, By Product

8.1. Direct-to-Consumer Laboratory Testing Market, by Product, 2023-2032

8.1.1 Medical Genetic Laboratory Testing

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Routine Clinical Laboratory Testing

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Direct-to-Consumer Laboratory Testing Market, By Test Type

9.1. Direct-to-Consumer Laboratory Testing Market, by Test Type, 2023-2032

9.1.1. Genetic Testing

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. COVID-19

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Cancer

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Diabetes Testing

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Disease Risk Assessment Testing

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Sexually Transmitted Disease Testing

9.1.6.1. Market Revenue and Forecast (2020-2032)

9.1.7. Routine Testing

9.1.7.1. Market Revenue and Forecast (2020-2032)

9.1.8. Complete Blood Count

9.1.8.1. Market Revenue and Forecast (2020-2032)

9.1.9. Complete Blood Count

9.1.9.1. Market Revenue and Forecast (2020-2032)

9.1.10. Thyroid Stimulating Hormone Testing

9.1.10.1. Market Revenue and Forecast (2020-2032)

9.1.11. Other

9.1.11.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Direct-to-Consumer Laboratory Testing Market, By Sample Type 

10.1. Direct-to-Consumer Laboratory Testing Market, by Sample Type, 2023-2032

10.1.1. Blood

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Urine

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Saliva

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Direct-to-Consumer Laboratory Testing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.1.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

Chapter 12. Company Profiles

12.1. 23andMe, Inc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Ambry Genetics Corp.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Ancestry.com LLC

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Any Lab Test Now, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Color Genomics, Inc

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Counsyl, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. DanteLabs Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Direct Laboratory Services, LLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Eastern Biotech & Life Sciences

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. EasyDNA

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms